[Pancreatic oncofetal antigen (POA)]. 1983

H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo

Recently, there has been an increasing interest in the diagnostic and prognostic usefulness of tumor-associated antigen of embryonic and fetal origin. Many approaches have been attempted to make an early diagnosis of the pancreatic cancer, where a specific screening blood test for the pancreatic cancer is required. By using antiserum to fetal pancreas, Banwo et al, discovered an oncofetal antigen that was present in human fetal pancreas, pancreatic tumor tissue, and sera from patients with the pancreatic cancer. Pancreatic oncofetal antigen (POA) was considered to be an oncofetal antigen for human pancreas, and its measurement seemed to be useful in the diagnosis of pancreatic cancer. But elevated levels of POA were also observed in the serum of some patients with cancer of the stomach, lung, colon, or liver as well as in the serum of some pregnant women and others with certain benign conditions. In summary, combined assay with various tumor markers was considered to be useful for the diagnosis of pancreatic cancer.

UI MeSH Term Description Entries
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo
May 1984, Gan no rinsho. Japan journal of cancer clinics,
H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo
September 1982, Rinsho byori. The Japanese journal of clinical pathology,
H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo
April 1981, Hepato-gastroenterology,
H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo
November 1986, Nihon Geka Gakkai zasshi,
H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo
February 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo
September 1978, Cancer,
H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo
April 1981, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo
December 1984, Nihon Gan Chiryo Gakkai shi,
H Mugitani, and H Furue, and M Kako, and F Hirota, and K Fuse, and T Takahashi, and K Sakamoto, and K Yamada, and M Suminaga, and M Ezaki, and R Judo
May 1985, Gut,
Copied contents to your clipboard!